相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy, safety, and biomarker analysis of neoadjuvant avelumab/axitinib in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after nephrectomy (NeoAvAx).
Axel Bex et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy
Pavlos Msaouel et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinoma
Nikos Kourtis et al.
NATURE CANCER (2022)
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma
Michael A. Gorin et al.
EUROPEAN UROLOGY ONCOLOGY (2022)
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
David A. Braun et al.
CANCER CELL (2021)
Phase I/IB trial of sitravatinib (Sitra) plus nivolumab (Nivo) plus ipilimumab (Ipi) in patients (pts) with advanced clear cell renal cell carcinoma (accRCC) or other solid malignancies.
Pavlos Msaouel et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues
Edwin R. Parra et al.
SCIENTIFIC REPORTS (2021)
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study
Marc Oliva et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
T. K. Choueiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Procedural Requirements and Recommendations for Multiplex Immunofluorescence Tyramide Signal Amplification Assays to Support Translational Oncology Studies
Edwin Roger Parra et al.
CANCERS (2020)
PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients with localized renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143).
Lauren Christine Harshman et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives
Sean W. Berquist et al.
INTERNATIONAL JOURNAL OF UROLOGY (2019)
PD-1 and LAG-3 Dominate Checkpoint Receptor-Mediated T-cell Inhibition in Renal Cell Carcinoma
Henning Zelba et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Evaluation of the spectrum selective RTK inhibitor sitravatinib in clear cell renal cell carcinoma (ccRCC) refractory to anti-angiogenic therapy (AAT).
Shubham Pant et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Sitravatinib potentiates immune checkpoint blockade in refractory cancer models
Wenting Du et al.
JCI INSIGHT (2018)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach
Brian M. Shinder et al.
FRONTIERS IN ONCOLOGY (2017)
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
Jianjun Gao et al.
CELL (2016)
Predictive biomarkers for checkpoint inhibitor-based immunotherapy
Geoffrey T. Gibney et al.
LANCET ONCOLOGY (2016)
Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer
Thomas Powles et al.
JAMA ONCOLOGY (2016)
The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma
Leonardo D. Borregales et al.
THERAPEUTIC ADVANCES IN UROLOGY (2016)
Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma
Marcella Callea et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
Jose A. Karam et al.
EUROPEAN UROLOGY (2014)
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma
Michel Choueiri et al.
CURRENT CLINICAL PHARMACOLOGY (2011)
Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery
Jonathan L. Silberstein et al.
BJU INTERNATIONAL (2010)
A modified toxicity probability interval method for dose-finding trials
Yuan Ji et al.
CLINICAL TRIALS (2010)
The Clavien-Dindo Classification of Surgical Complications Five-Year Experience
Pierre A. Clavien et al.
ANNALS OF SURGERY (2009)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
分享论文
